Nothing Special   »   [go: up one dir, main page]

Velho et al., 1997 - Google Patents

Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families

Velho et al., 1997

View PDF
Document ID
9081247386294869863
Author
Velho G
Blanche H
Vaxillaire M
Bellanne-Chantelot C
Pardini V
Timsit J
Passa P
Deschamps I
Robert J
Weber I
Marotta D
Pilkis S
Lipkind G
Bell G
Froguel P
Publication year
Publication venue
Diabetologia

External Links

Snippet

Mutations in glucokinase are associated with defects in insulin secretion and hepatic glycogen synthesis resulting in mild chronic hyperglycaemia, impaired glucose tolerance or diabetes mellitus. We screened members of 35 families with features of maturity-onset …
Continue reading at link.springer.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Similar Documents

Publication Publication Date Title
Velho et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families
Velho et al. Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young
Devi et al. Crystallin gene mutations in Indian families with inherited pediatric cataract
Steinle et al. Eating behavior in the Old Order Amish: heritability analysis and a genome-wide linkage analysis
Hani et al. A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus.
Engert et al. 5′ flanking variants of resistin are associated with obesity
Sharon et al. X-linked retinitis pigmentosa: mutation spectrum of the RPGR and RP2 genes and correlation with visual function
Zouali et al. Linkage analysis and molecular scanning of glucokinase gene in NIDDM families
de Carvalho et al. Enhanced S-cone syndrome: spectrum of clinical, imaging, electrophysiologic, and genetic findings in a retrospective case series of 56 patients
US20080045456A1 (en) Treatment of disease
Charif et al. Dominant ACO2 mutations are a frequent cause of isolated optic atrophy
De Backer et al. Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome
Sambuughin et al. Identification and functional characterization of a novel ryanodine receptor mutation causing malignant hyperthermia in North American and South American families
Gonsorčíková et al. Autosomal inheritance of diabetes in two families characterized by obesity and a novel H241Q mutation in NEUROD1
Mabuchi et al. Analysis of myocilin gene mutations in Japanese patients with normal tension glaucoma and primary open‐angle glaucoma
Qian et al. Clinical evaluation and mitochondrial DNA sequence analysis in three Chinese families with Leber’s hereditary optic neuropathy
Rauf et al. Novel mutations in LTBP2 identified in familial cases of primary congenital glaucoma
Riveiro-Alvarez et al. Correlation of genetic and clinical findings in Spanish patients with X-linked juvenile retinoschisis
Pepe et al. Fibrillin‐1 (FBN1) gene frameshift mutations in Marfan patients: genotype–phenotype correlation
Yzer et al. CRB1 heterozygotes with regional retinal dysfunction: implications for genetic testing of leber congenital amaurosis
Hejtmancik et al. Prenatal diagnosis of α1-antitrypsin deficiency by restriction fragment length polymorphisms, and comparison with oligonucleotide probe analysis
Lin et al. A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy
Jin et al. Analysis of association between common variants of uncoupling proteins genes and diabetic retinopathy in a Chinese population
Biery et al. The β3-adrenergic receptor TRP64ARG polymorphism and obesity in Alaskan Eskimos
Tran-Viet et al. Mutation in collagen II alpha 1 isoforms delineates Stickler and Wagner syndrome phenotypes